Pilot Study of Throat Packs Soaked in Gengigel Spray in Patients Undergoing Elective Surgery
Launched by UNIVERSITY OF MALAYA · Apr 19, 2025
Trial Information
Current as of July 04, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring a new way to keep throat packs used in surgery moist by using a product called Gengigel spray instead of the usual saline solution. Throat packs are important during surgeries involving the mouth and throat because they help prevent blood and other substances from entering the lungs, which can cause problems. Gengigel is made from hyaluronic acid, which is known to help heal tissues and reduce inflammation. The goal of this study is to see if using Gengigel can improve recovery after surgery by promoting healing and reducing soreness.
To participate in this trial, you should be between 18 and 60 years old and generally healthy, as indicated by a low risk of complications from anesthesia. Unfortunately, if you have a sore throat before the surgery or if there are concerns about your airway, you may not be eligible. Participants will receive the throat pack moistened with Gengigel during their surgical procedure and will be monitored for any changes in soreness or healing afterward. This could be an exciting opportunity to help improve surgical care and recovery for future patients!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Classified as ASA I-II, indicating a relatively low risk of complications from anesthesia
- • 2. Aged between 18 and 60 years, which represents a typical adult surgical population
- • 3. Both male and female patients, ensuring gender inclusivity and representation in the study findings
- Exclusion Criteria:
- • 1. Existing sore throat prior to surgery, which could affect the baseline measurement of postoperative sore throat.
- • 2. Anticipation of a difficult airway, as these patients may require specialized intubation techniques that are not standardized across the study.
- • 3. More than two attempts at endotracheal tube (ETT) insertion, as multiple attempts could cause additional trauma and skew the study outcomes.
- • 4. Any trauma occurring during intubation, which could independently contribute to postoperative sore throat and other complications
About University Of Malaya
The University of Malaya, a premier research institution in Malaysia, is dedicated to advancing medical knowledge and improving healthcare outcomes through innovative clinical trials. With a commitment to excellence in research and education, the University collaborates with leading healthcare professionals and researchers to explore cutting-edge treatments and interventions. Its clinical trial programs focus on various health challenges, aiming to translate scientific discoveries into practical applications that benefit diverse populations. By fostering a multidisciplinary approach, the University of Malaya continues to contribute significantly to the global medical research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kuala Lumpur, , Malaysia
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported